Commodore Capital LP Portfolio Holdings

Commodore Capital LP

  • $998 Million
  • Q4 2024

Commodore Capital LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $998 Million distributed in 31 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Merus N.V. with a value of $163M, Vaxcyte, Inc. with a value of $133M, Nuvalent, Inc. with a value of $127M, Xenon Pharmaceuticals Inc. with a value of $107M, and Vera Therapeutics, Inc. with a value of $82.8M.

Examining the 13F form we can see an decrease of $179M in the current position value, from $1.18B to 998M.

Commodore Capital LP is based out at New York, NY

Below you can find more details about Commodore Capital LP portfolio as well as his latest detailed transactions.

Portfolio value $998 Million
Healthcare: $998 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 31
  • Current Value $998 Million
  • Prior Value $1.18 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 4 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Commodore Capital LP Portfolio

Follow Commodore Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commodore Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Commodore Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email